Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11591600 Long double-stranded RNA for RNA interference

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
OliX Pharmaceuticals
OliX Pharmaceuticals
Date Filed
February 12, 2018
Date of Patent
February 28, 2023
Patent Applicant
OliX Pharmaceuticals
OliX Pharmaceuticals
Patent Application Number
16484643
Patent Citations
‌
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
‌
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
‌
US Patent 10064801 RNA complexes that inhibit melanin production
‌
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
‌
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11591600
Patent Primary Examiner
‌
Amy H Bowman
CPC Code
‌
A61K 31/713

Find more entities like US Patent 11591600 Long double-stranded RNA for RNA interference

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo